R. Vamshikrishna

Saroglitazar as a Metabolic Modulator: A Critical Narrative Review of PPAR-Driven Therapeutic Actions

V. Sreshta, K. Meghana, K. Chandrashekar Patel, R. Vamshikrishna & G. Narendar Naik · Asian Journal of Medical Principles and Clinical Practice · 2026

Saroglitazar is an orally active dual peroxisome proliferator-activated receptor alpha/gamma agonist developed to couple triglyceride-rich lipoprotein lowering with insulin-sensitising activity while limiting the adverse effects historically associated with broad glitazar pharmac...